Cardioprotection by inhibition of coagulation and inflammation in myocardial infarction
Ended Project Grant Awarded Last action
- Award ID
- R43HL142325
- Recipient
-
Evas Therapeutics LLC UEI N7UMM55RJ7S5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,999
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Place of performance
- Missouri, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $299,999 |
Quick answers
Who received award R43HL142325?
R43HL142325 was awarded to Evas Therapeutics LLC by National Heart Lung and Blood Institute (National Institutes of Health) on August 1, 2018.
How much is award R43HL142325 worth?
$299,999 has been obligated on R43HL142325.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award